Clinical trial

Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

NCT03709082

Study summary

ClinicalTrials.gov

Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE1, PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

6 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Palbociclib 75mg Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Letrozole 2.5mg Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention T-DM1 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Palbociclib 100mg Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Palbociclib 125mg Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Palbociclib Normalized identity: palbociclib View linked drug · Find medicine records · Find other trials using this name

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2018-10-15

PhasePHASE1 / PHASE2

Conditions

HER2-positive Breast Cancerunresolved

Breast Cancer Metastaticunresolved

Interventions

Palbociclib 75mgDRUG

Letrozole 2.5mgDRUG

T-DM1DRUG

Palbociclib 100mgDRUG

Palbociclib 125mgDRUG

PalbociclibDRUG · verified · RxNorm: palbociclib

Sponsors & collaborators

University of Kansas Medical Centerlead sponsor

Pfizercollaborator

Mapped research locations

Kansas CityKansas, United States2 Kansas CityMissouri, United States1 Overland ParkKansas, United States1 Lee's SummitMissouri, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03709082 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.